ClinicalTrials.gg
Sign In
Biological

Allogenic cryopreserved human umbilical cord tissue clinical trials

Also written TTAX01.

studies test it
4
open now
0
in phase 3
2
first study started
2017

How each study uses allogenic cryopreserved human umbilical cord tissue is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

TTAX01
4

Studies by the year they started

4 studies that test it; most in 2020 (2)

Studies that test allogenic cryopreserved human umbilical cord tissue, by start year
YearStudies
20171
20191
20202

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
2

Who runs them

Industry 4 · Other 0

BioTissue Holdings, Inc (4)

Studies

Open first, then newest update. How each study uses allogenic cryopreserved human umbilical cord tissue is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4